New Insights into Endothelial Dysfunction in Cardiometabolic Diseases: Potential Mechanisms and Clinical Implications

The endothelium is a monocellular layer covering the inner surface of blood vessels. It maintains vascular homeostasis regulating vascular tone and permeability and exerts anti-inflammatory, antioxidant, anti-proliferative, and anti-thrombotic functions. When the endothelium is exposed to detrimenta...

Full description

Bibliographic Details
Main Authors: Giovanna Gallo, Carmine Savoia
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/25/5/2973
_version_ 1797264376631132160
author Giovanna Gallo
Carmine Savoia
author_facet Giovanna Gallo
Carmine Savoia
author_sort Giovanna Gallo
collection DOAJ
description The endothelium is a monocellular layer covering the inner surface of blood vessels. It maintains vascular homeostasis regulating vascular tone and permeability and exerts anti-inflammatory, antioxidant, anti-proliferative, and anti-thrombotic functions. When the endothelium is exposed to detrimental stimuli including hyperglycemia, hyperlipidemia, and neurohormonal imbalance, different biological pathways are activated leading to oxidative stress, endothelial dysfunction, increased secretion of adipokines, cytokines, endothelin-1, and fibroblast growth factor, and reduced nitric oxide production, leading eventually to a loss of integrity. Endothelial dysfunction has emerged as a hallmark of dysmetabolic vascular impairment and contributes to detrimental effects on cardiac metabolism and diastolic dysfunction, and to the development of cardiovascular diseases including heart failure. Different biomarkers of endothelial dysfunction have been proposed to predict cardiovascular diseases in order to identify microvascular and macrovascular damage and the development of atherosclerosis, particularly in metabolic disorders. Endothelial dysfunction also plays an important role in the development of severe COVID-19 and cardiovascular complications in dysmetabolic patients after SARS-CoV-2 infection. In this review, we will discuss the biological mechanisms involved in endothelial dysregulation in the context of cardiometabolic diseases as well as the available and promising biomarkers of endothelial dysfunction in clinical practice.
first_indexed 2024-04-25T00:27:55Z
format Article
id doaj.art-a21738181dbe426abea70cbf92a06c6e
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-04-25T00:27:55Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-a21738181dbe426abea70cbf92a06c6e2024-03-12T16:47:05ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672024-03-01255297310.3390/ijms25052973New Insights into Endothelial Dysfunction in Cardiometabolic Diseases: Potential Mechanisms and Clinical ImplicationsGiovanna Gallo0Carmine Savoia1Clinical and Molecular Medicine Department, Faculty of Medicine and Psychology, Sant’Andrea Hospital, Sapienza University of Rome, Via di Grottarossa 1035–1039, 00189 Rome, ItalyClinical and Molecular Medicine Department, Faculty of Medicine and Psychology, Sant’Andrea Hospital, Sapienza University of Rome, Via di Grottarossa 1035–1039, 00189 Rome, ItalyThe endothelium is a monocellular layer covering the inner surface of blood vessels. It maintains vascular homeostasis regulating vascular tone and permeability and exerts anti-inflammatory, antioxidant, anti-proliferative, and anti-thrombotic functions. When the endothelium is exposed to detrimental stimuli including hyperglycemia, hyperlipidemia, and neurohormonal imbalance, different biological pathways are activated leading to oxidative stress, endothelial dysfunction, increased secretion of adipokines, cytokines, endothelin-1, and fibroblast growth factor, and reduced nitric oxide production, leading eventually to a loss of integrity. Endothelial dysfunction has emerged as a hallmark of dysmetabolic vascular impairment and contributes to detrimental effects on cardiac metabolism and diastolic dysfunction, and to the development of cardiovascular diseases including heart failure. Different biomarkers of endothelial dysfunction have been proposed to predict cardiovascular diseases in order to identify microvascular and macrovascular damage and the development of atherosclerosis, particularly in metabolic disorders. Endothelial dysfunction also plays an important role in the development of severe COVID-19 and cardiovascular complications in dysmetabolic patients after SARS-CoV-2 infection. In this review, we will discuss the biological mechanisms involved in endothelial dysregulation in the context of cardiometabolic diseases as well as the available and promising biomarkers of endothelial dysfunction in clinical practice.https://www.mdpi.com/1422-0067/25/5/2973endotheliumdiabetesmetabolic syndromeendothelial dysregulationcardiometabolic diseases
spellingShingle Giovanna Gallo
Carmine Savoia
New Insights into Endothelial Dysfunction in Cardiometabolic Diseases: Potential Mechanisms and Clinical Implications
International Journal of Molecular Sciences
endothelium
diabetes
metabolic syndrome
endothelial dysregulation
cardiometabolic diseases
title New Insights into Endothelial Dysfunction in Cardiometabolic Diseases: Potential Mechanisms and Clinical Implications
title_full New Insights into Endothelial Dysfunction in Cardiometabolic Diseases: Potential Mechanisms and Clinical Implications
title_fullStr New Insights into Endothelial Dysfunction in Cardiometabolic Diseases: Potential Mechanisms and Clinical Implications
title_full_unstemmed New Insights into Endothelial Dysfunction in Cardiometabolic Diseases: Potential Mechanisms and Clinical Implications
title_short New Insights into Endothelial Dysfunction in Cardiometabolic Diseases: Potential Mechanisms and Clinical Implications
title_sort new insights into endothelial dysfunction in cardiometabolic diseases potential mechanisms and clinical implications
topic endothelium
diabetes
metabolic syndrome
endothelial dysregulation
cardiometabolic diseases
url https://www.mdpi.com/1422-0067/25/5/2973
work_keys_str_mv AT giovannagallo newinsightsintoendothelialdysfunctionincardiometabolicdiseasespotentialmechanismsandclinicalimplications
AT carminesavoia newinsightsintoendothelialdysfunctionincardiometabolicdiseasespotentialmechanismsandclinicalimplications